Skip to main content
. 2022 Apr 28;11(9):2488. doi: 10.3390/jcm11092488

Table 1.

General characteristics of included participants.

Characteristic Total (n = 77) Control (n = 38) MAFLD (n = 39) p-Value
Age (years), median (IQR) 46 (30–56) 30 (27–41.5) 53 (48.5–58.5) <0.001
Gender (male), n (%) 35 (45.45) 17 (44.74) 18 (46.15) 0.901
Marital Status: <0.001
Single, n (%) 21 (27.27) 18 (47.37) 3 (7.69)
Married, n (%) 51 (66.23) 19 (50) 32 (82.05)
Divorced, n (%) 3 (3.9) 0 (0) 3 (7.69)
Widow, n (%) 2 (2.6) 1 (2.63) 1 (2.56)
Married (yes), n (%) 51 (66.23) 19 (50) 32 (82.05) 0.003
Education:
Primary School, n (%) 3 (3.9) 0 (0) 3 (7.69) <0.001
Middle School, n (%) 12 (15.58) 4 (10.53) 8 (20.51)
High School, n (%) 27 (35.06) 7 (18.42) 20 (51.28)
Undergraduate Course, n (%) 6 (7.79) 5 (13.16) 1 (2.56)
University, n (%) 26 (33.77) 21 (55.26) 5 (12.82)
Post-graduate, n (%) 3/77 (3.9) 1 (2.63) 2 (5.13)
Menopausal status: * <0.001
Premenopause 21 (50) 18 (42.86) 3 (7.14)
Menopause 21 (50) 3 (7.14) 18 (42.86)
Metabolic syndrome (yes), n (%) 32 (41.56) 2 (5.26) 30 (76.92) <0.001
BMI, median (IQR) 26.57 (22.22–31.44) 22.18 (20.15–24.95) 31.18 (28.08–34.98) <0.001
Obesity (yes), n (%) 22 (28.57) 1 (2.63) 21 (53.85) <0.001
Hepatic steatosis (US) (yes), n (%) 39 (50.65) 0 (0) 39 (100) <0.001
SteatoTest score, median (IQR) 0.39 (0.13–0.62) 0.13 (0.08–0.21) 0.62 (0.51–0.72) <0.001
SBP-mean (mmHg), median (IQR) 124.5 (116–137) 120.75 (112.5–125.88) 133 (122.25–148.25) <0.001
DBP-mean (mmHg), median (IQR) 79 (74–84) 75 (70.75–79) 83.5 (78.25–89) <0.001
Number or medications, median (IQR) 1 (0–4) 0 (0–0) 3 (1.5–5.5) <0.001

* Reported in 42 female subjects. BMI—Body mass index; DBP—Diastolic blood pressure; IQR—Interquartile range; MAFLD—Metabolic-associated fatty liver disease; SBP—Systolic blood pressure.